Califf: Sponsors Should Go Beyond Letter Of Law With Trial Diversity Plans

diverse group of people with hands in the middle
FDA Commissioner Robert Califf said trial diversity will improve through analysis of trial diversity plans. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Diversity & Inclusion

More from R&D